American Century Companies’s Adamas Pharmaceuticals ADMS Stock Holding History

American Century Companies’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-163,992	Closed	-$1.4M	–	1355
2018 Q4	$1.4M	Buy	163,992 +38,779	+31%	+$504K	﹤0.01%	1021
2018 Q3	$2.51M	Buy	125,213 +26,503	+27%	+$622K	﹤0.01%	997
2018 Q2	$2.55M	Buy	98,710 +25,690	+35%	+$711K	﹤0.01%	981
2018 Q1	$1.75M	Buy	73,020 +10,760	+17%	+$339K	﹤0.01%	1018
2017 Q4	$2.11M	Buy	+62,260	New	+$1.74M	﹤0.01%	1000
2015 Q4	–	Sell	-35,449	Closed	-$593K	–	1417
2015 Q3	$593K	Buy	+35,449	New	+$806K	﹤0.01%	1189

Other funds holding ADMS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

American Century Companies's ADMS Position: Q1 2019 in Review

American Century Companies sold out of Adamas Pharmaceuticals (ADMS) in Q1 2019, closing a stake of 163,992 shares — an estimated $1.4M sold.

American Century Companies first reported a position in ADMS in Q3 2015 and held it in 6 quarters. The position peaked at $2.55M in Q2 2018. 99 funds tracked by Wall St. Rank hold ADMS as of Q1 2019.

American Century Companies reported no remaining Adamas Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
American Century Companies sold 163,992 Adamas Pharmaceuticals shares in Q1 2019, an estimated $1.4M.
American Century Companies first reported a position in Adamas Pharmaceuticals in Q3 2015 and held it in 6 quarters.
American Century Companies's Adamas Pharmaceuticals position peaked at $2.55M in Q2 2018.
99 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2019.

Based on American Century Companies's 13F filing for Q1 2019, filed 14 May 2019.